Supplemental materials for the manuscript entitled "CLOFAZIMINE-INDUCED CUTANEOUS HYPERPIGMENTATION AS A SOURCE OF STIGMA IN THE TREATMENT OF LEPROSY: A CROSS-SECTIONAL STUDY"
Mendeley supplemental figure 1. The 21 points used to measure skin color by spectrophotometry. Both sun-exposed and non-sun-exposed areas were tested. Mendeley supplemental figure 2. Representative photos illustrate clofazimine-induced cutaneous hyperpigmentation. It did not occur homogeneously in all body areas in all patients. (A) Virchowian patient, 11 months of MDT. (B) Virchowian patient, 11 months of MDT. (C) Virchowian patient, 12 months of MDT. (D) Dimorph patient, 24 months of MDT. Mendeley supplemental figure 3. Variation in the individual typology angle (ITA°) in nonlesion areas according to sunlight exposure. Lower ITA° values represent darker skin tones. Supplementary methods describing measuring of skin color. Supplementary material describing the structured questionnaire.
Conselho Nacional de Desenvolvimento Científico e Tecnológico
(CNPq, No 130314/2020-0)
Heiser Program of the New York Community Trust for Research in Leprosy
(No P15-000827, No P16-000796, and No P18-000250).